Skip to content

Assessment of Lung Movement With Computed Tomography (CT)

Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03068091
Enrollment
25
Registered
2017-03-01
Start date
2017-07-01
Completion date
2018-10-31
Last updated
2020-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Keywords

Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis

Brief summary

The purpose of this study is to determine whether patient with ILD have altered lung compliance on chest CT before they have macroscopic structural changes on CT.

Detailed description

Interstitial lung disease (ILD) is a group of lung disorders in which the lung tissues become inflamed and then damaged. Idiopathic Pulmonary Fibrosis (IPF) is one of the subtypes of ILD which has characteristic histological and CT features. It is well known that microscopic fibrosis occurs in the lungs of IPF patients well before the structural changes of fibrosis become apparent on CT. By combining sophisticated image analysis with CT scans obtained at full inspiration and full expiration, it may be possible to detect earlier changes of IPF than currently possible by looking at macro structural features alone. With the recent development of new therapeutics for IPF, early detection of the disease and improved monitoring of treatment efficacy will become important. Using CT to assess regional lung compliance has the potential to become an easily translated clinical tool.

Interventions

DEVICEChest CT

Inspiration and expiration chest CT

Measure lung function

Sponsors

Henry M. Jackson Foundation for the Advancement of Military Medicine
CollaboratorOTHER
University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants will undergo CT and pulmonary function testing.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects with ILD: Subjects must have a physician diagnosis of ILD and be in stable pulmonary condition at the time of the CT * Healthy subjects: Subjects must have no history of pulmonary disease and smoked less than 100 cigarettes in their lifetime

Exclusion criteria

* Subjects less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Lung Motion as Assessed by CTStudy visit 1 of a single visit studyA computer algorithm will compare the inspiration and expiration CT scans to determine regional lung motion.

Secondary

MeasureTime frameDescription
Lung Motion: Lobar Strain Which is a RatioStudy visit 1 of a single visit studyLobar strain (S): the volumetric strain of each lobe i \[i = Right Upper (RU), Right Lower (RL), Left Lower (LL), and Left Upper (LU)\] as the difference in lobe volume between the expanded and contracted states, normalized by the lobe volume in the expanded state

Countries

United States

Participant flow

Participants by arm

ArmCount
Pulmonary Assessment
All participants will undergo a Chest CT scan and pulmonary function testing Chest CT: Inspiration and expiration chest CT Pulmonary Function Testing: Measure lung function
24
Total24

Baseline characteristics

CharacteristicPulmonary Assessment
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
21 Participants
Region of Enrollment
United States
24 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 24
other
Total, other adverse events
0 / 24
serious
Total, serious adverse events
0 / 24

Outcome results

Primary

Lung Motion as Assessed by CT

A computer algorithm will compare the inspiration and expiration CT scans to determine regional lung motion.

Time frame: Study visit 1 of a single visit study

Population: A total of 9 IPF subjects and 13 control subject had CT scans that could be analyzed.

ArmMeasureGroupValue (MEAN)Dispersion
Pulmonary AssessmentLung Motion as Assessed by CTLung Volume Inspiration, IPF4.07 LitersStandard Deviation 0.98
Pulmonary AssessmentLung Motion as Assessed by CTLung Volume Inspiration, Control5.56 LitersStandard Deviation 0.9
Pulmonary AssessmentLung Motion as Assessed by CTLung Volume Expiration, IPF1.82 LitersStandard Deviation 0.3
Pulmonary AssessmentLung Motion as Assessed by CTLung Volume Expiration, Control2.46 LitersStandard Deviation 0.56
Secondary

Lung Motion: Lobar Strain Which is a Ratio

Lobar strain (S): the volumetric strain of each lobe i \[i = Right Upper (RU), Right Lower (RL), Left Lower (LL), and Left Upper (LU)\] as the difference in lobe volume between the expanded and contracted states, normalized by the lobe volume in the expanded state

Time frame: Study visit 1 of a single visit study

Population: 9 idiopathic pulmonary fibrosis (IPF) and 13 control subjects (N=22) had CT's that were able to be analyzed for lobar strain (lung motion).

ArmMeasureGroupValue (MEAN)Dispersion
Pulmonary AssessmentLung Motion: Lobar Strain Which is a RatioIPF0.37 RatioStandard Deviation 0.15
Pulmonary AssessmentLung Motion: Lobar Strain Which is a RatioControl0.39 RatioStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026